Rate My Professor Sharron Hall

Sharron Hall serves as Research Coordinator in the School of Medicine and Public Health within the College of Health, Medicine and Wellbeing at the University of Newcastle. She earned her Bachelor of Science from the same institution. Her research expertise lies in managing projects on the immunology of the upper respiratory tract, with particular emphasis on immune function in elite athletes, infants at risk of sudden infant death syndrome, and children suffering from otitis media with effusion. Hall utilizes saliva samples to investigate mucosal immune function and has conducted studies on Aboriginal health pathology. Additionally, she develops enzyme-linked immunoassays, manages ethics and safety protocols, trains research staff, and oversees research funding.

Hall's contributions extend to laboratory investigations of the protein midkine in relation to cancer, heart disease, and kidney disease. She has led collaborations between Indigenous and non-Indigenous researchers in ear health research and service delivery, with a strong focus on childhood ear infections and hearing loss among Aboriginal and Torres Strait Islander children. Her extensive publication record includes journal articles such as "Measurement of complement activation via plasma-soluble C5b-9 comparison with terminal complement complex staining in a series of kidney biopsies" (2023, Kidney & Blood Pressure Research), "Otitis media and quality of life in NSW Aboriginal children" (2022, Australian Journal of Otolaryngology), "'Sometimes they're gammin, playing tricks, but sometimes it's ears': The perspectives of urban parents and carers of young Aboriginal and Torres Strait Islander children on their journey to diagnosis of persistent ear health and hearing problems" (2021, Public Health Research & Practice), and "Heparin Administration, but Not Myocardial Ischemia or Necrosis, Leads to Midkine Elevation" (2020, Journal of Cardiovascular Translational Research). Conference presentations cover topics like salivary IgA in COPD patients during pulmonary rehabilitation (2019), midkine as a predictive biomarker in metastatic colorectal cancer (2015), and maternal inflammation effects in Indigenous pregnancies (2014). Through these efforts, Hall has significantly impacted research on inflammatory responses, Indigenous health disparities, and biomarker development in clinical settings.